Tag: Pfizer

After being largely dismissed by investors due to plummeting COVID-19 revenue and looming patent expirations, pharmaceutical giant Pfizer is suddenly ...

Pfizer is making significant strides in reshaping its post-pandemic trajectory, with recent clinical trial results generating substantial excitement among investors. ...

After an extended period of decline, Pfizer's shares are attracting renewed attention from Wall Street. A powerful combination of regulatory ...

Pharmaceutical titan Pfizer is aggressively reshaping its identity beyond being perceived as a pandemic beneficiary, making a substantial strategic commitment ...

Pfizer's recent $7 billion acquisition of biotechnology firm Metsera has triggered a wave of market skepticism rather than celebration. The ...

In a landmark corporate acquisition, pharmaceutical titan Pfizer has successfully outmaneuvered competitor Novo Nordisk, securing the prized drug developer Metsera ...

The pharmaceutical industry is witnessing an intense bidding war as Pfizer competes against Danish rival Novo Nordisk for control of ...

The pharmaceutical sector is witnessing a dramatic takeover contest as Pfizer confronts an unexpected challenge to its previously agreed acquisition. ...

Pfizer has achieved significant regulatory milestones for its vaccine portfolio, with Singapore becoming the first Southeast Asian nation to approve ...

Pfizer is positioning itself for a significant strategic move within the multi-billion dollar vaccine market. As revenue from its COVID-19 ...